BlueSky says that conventional treatment for equine sarcoids, which are induced by tumour antigens E6 and E7 of the bovine papillomavirus, have only limited effect and typically result in the recurrence of the tumours.
However, research published by the company in PLoSONE1 showed that sarcoids treated with delNS/E6E7 were completely and permanently eliminated.
For the study, 29 horses were treated with different regimes involving direct injection into the tumours over three years.
Visible and very significant regression of the sarcoids was achieved in 20 of the treated horses, and 100% regression of the sarcoids in 10 equine patients.
Thomas Muster, CEO of BlueSky Immunotherapies said: "The complete elimination of very aggressive and difficult-to-cure equine sarcoids is yet another important proof of the potential offered by our delNS platform."
In addition, the systemic delNS-mediated immune stimulation eliminated non-injected sarcoids and the papillomavirus that caused the sarcoids.
Thomas added: "We are therefore confident that we will also be able to successfully heal and/or eliminate the cervical tumours of the women enrolled in the clinical trials currently under way."
Reference
Open to all veterinary professionals looking to enhance their knowledge and skills in emergency and critical care, this year's Congress has a lineup of over 30 internationally-renowned speakers and leading clinicians and offers up to 70 hours of CPD.
This year’s keynote speaker is specialist transplant nurse and chair of the UK One Health Coordination Group, Helen Ballantyne, and organisers will also be welcoming veterinary nurse Ken Yagi, formerly program director of the CPR simulation lab at Cornell University, who’ll deliver an update on the new RECOVER (CPR) guidelines being released this year.
Simon Hagley, ECC Specialist and Clinical Director at Vets Now hospital in Manchester said: “We are confident our 2024 programme offers something for everyone, no matter what stage of your ECC career you are at, from students through to specialists and everything in between.
"We listened to delegate feedback from last year’s event, and we have brought back some firm favourites including our ’Controversies’ and ‘Joined Up Thinking sessions’, but we have introduced exciting new streams including 'Catastrophic case conversations'.
“We’ve also we’ve extended the popular nursing streams from last year to span two entire days and lunchtime case presentations from interns across the country are also on the programme.”
https://www.vets-now.com/congress
Direct Line has revealed the results of a small survey which found that 78% of veterinary surgeons had treated pets for ingesting human medicines in the last year.
100 vets took part in the study, of which 28% reported that they had cases where owners had deliberately given their pet human medication in an attempt to help them. Some vets described incidents of owners believing paracetamol will help conditions like arthritis and limping. In one case an owner gave their cat a quarter of paracetamol every day in an attempt to stop its pain, which instead resulted in the cat dying.
The most common types of medication ingested were:
In total, the veterinary surgeons who took part in the survey reported 243 cases of accidental ingestion of human medicines. The majority (76%) of cases involved dogs. However incidents involving cats, rabbits and guinea pigs were also reported.
BVA President Gudrun Ravetz said: "Veterinary View not only highlights some of the veterinary profession's fantastic work, but complements our joint project with RCVS, Vet Futures, in exploring how the profession can best shape its own future. We hope it will stimulate debate among vets, and the wider community in which we work, about both the big challenges and opportunities that the veterinary profession is facing."
The series includes a number of videos which showcase more recent industry developments:
Stem Cell therapy for the treatment of canine osteoarthritis (VetCell Therapeutics)
Pharmtrax, a mobile device for vets to record work and dispensing on the farm (Henry Schein Animal Health)
Hormone implants as an alternative to castration (Virbac Animal Health)
Practice management support from Zoetis
Preventing an epidemic of equine flu (Merial Animal Health)
Following a two-year postponed judgment, the Disciplinary Committee (DC) of the Royal College of Veterinary Surgeons last week warned a Cambridgeshire veterinary surgeon as to his future conduct, after he had been convicted in 2006 for causing death by careless driving whilst under the influence of alcohol.
In September 2007, the Committee heard that Peter Hanlon MRCVS, of Soham in Cambridgeshire, had been involved in a road traffic accident in February 2006. Mr Hanlon's car had drifted across the road and collided with an oncoming car driven by James Barber who was accompanied by his wife, Ivy. Mr Barber was pronounced dead at the scene and both Mrs Barber and Mr Hanlon sustained injuries.
At the initial hearing, Mr Hanlon admitted the conviction (for which he had been sentenced to 30 months in prison and received a four-year driving ban) and the charge that it rendered him unfit to practise veterinary surgery. The Committee decided to postpone its judgment for two years on the agreement that Mr Hanlon would undertake to abstain from alcohol and to submit quarterly medical reports and six-monthly CPD (continuing professional development) reports to the Committee chairman.
At the resumed hearing last week, the Committee carefully considered Mr Hanlon's written and oral submissions, and accepted that he had fully complied with these undertakings. He had abstained from alcohol since the day after the accident, produced an "exemplary" CPD record and provided impressive reports from his employers concerning his professional competence.
In addition, Mr Hanlon, who spent around 14 months in prison and remained on licence until July 2009, also reiterated to the Committee his remorse for the death of Mr Barber and respect for his family.
The Committee was mindful of its duty to maintain confidence in the veterinary profession and uphold proper standards of conduct. Whilst it did not consider it necessary to postpone judgment again, it felt that Mr Hanlon should be warned about his future conduct.
Caroline Freedman, chairing the Committee, concluded: "As this case has demonstrated, and as Mr Hanlon himself has fully recognised, abuse of alcohol can lead to far reaching consequences in personal and professional lives and the lives of others."
TR Biosurgical will be officially launching its new surgical treatment for canine glaucoma at the American College of Veterinary Ophthalmologists annual conference in Chicago at the start of November.
TR-ClarifEYE is an sub-scleral implant placed in the eye in a procedure that takes around 30 minutes.
TR Biosurgical CEO Craig Woods DVM said: "TR-ClarifEYE is made from new silicone substrate subjected to a unique process which reduces fibrosis and enhances healing."
"Until now, the primary treatment options for canine glaucoma have been laser surgery, cryosurgery, evisceration or enucleation. Certain procedures can be either complicated and expensive, or fail to save the eye. Previous implants have met with only limited success, and TR-ClarifEYE appears to overcome many of the problems with glaucoma implants."
"This new implant is a relatively easy surgical approach. It has limited post-op complications. It seems to provide long term glaucoma management in the majority of patients, most of which are able to reduce medications."
For more information about TR-ClarifEYE, visit: http://www.petglaucoma.com
Practitioners interested in learning more about this procedure, click here and 'start conversation' with Craig
Pfizer's Vet Support+ has launched the Practice Management Academy, which offers online training in the key management disciplines required to run a successful veterinary business.
There are twelve courses which cover four key areas of management: financial operations, staff management, client relations and marketing. Participants can choose to study individual courses, a specific area of management, or enrol in the full Practice Management Academy.
The courses are four weeks in length and contribute up to ten hours of CPD learning through a mix of interactive activities, case studies, questions and a student learning forum.
Each course is also allocated a Pfizer Business Consultant to work as an online expert tutor, posing questions and stimulating forum discussion amongst the students.
Pfizer says that the significant cost saving e-learning represents over external CPD is making the Academy a popular choice for all members of the practice team, especially those who may be taking on new management responsibilities or those looking for a refresher. According to the company, one large vet group has already taken twenty places on each of the courses to improve the practice management skills across its extensive team.
Ned Flaxman, Director Business Innovation said: "Using an E-Learning platform is a well-trodden path, ideal for busy individuals wishing to improve or gain new practice management skills without leaving the surgery, or sofa. However, unlike some e-learning which can leave the participant feeling like they are gaining theoretical know-how only, and working in somewhat of a silo, our Academy offers an 'online campus'. This provides a flexible, convenient and supportive training environment for shared theory and practical learning with other colleagues from the veterinary profession under the guidance of e-tutors and experts."
For further details visit http://www.vetsupportplus.co.uk/
Andy Moores said: "Elbow replacement surgery, despite advancements in both the implant and technique, remains a complex procedure with a demanding rehabilitation process.
"However, for the right candidates, elbow replacement offers the potential for significant improvement in joint function and pain relief, transforming the lives of dogs that would otherwise suffer from permanent discomfort."
The third generation TATE elbow has had a complete redesign to overcome some of the issues associated with the first and second generation models, and the Iowa State system which preceded them.
There are around 15 surgeons qualified to perform the procedure in the world, three in the UK, and Andy is the only one in the South East.
Andy added: "The advancements in the TATE Elbow system represent a significant leap forward in veterinary orthopaedic surgery.
"End-stage elbow osteoarthritis is a horrible condition which can leave dogs in chronic pain and with no good treatment options.
"Being certified to perform third-generation TATE elbow replacements allows us to offer our patients the most advanced treatment options available, giving them the best chance for a pain-free, functional life."
www.mooresortho.com info@mooresortho.com
Clare (pictured) who is currently the General Dental Council’s Interim Executive Director for Legal and Governance, will be joining the RCVS as its most senior legal officer at the end of March 2025.
A qualified solicitor, Clare started her practice as a Solicitor Advocate in criminal law, before undertaking roles in regulatory bodies in the healthcare and financial sector.
She joined the General Dental Council in March 2023 and has been in her current role there since March last year.
When she joins the College, Clare will have a dual role.
As Registrar she will be responsible for keeping, maintaining and publishing Registers of veterinary surgeons and veterinary nurses, including oversight of the various mechanisms via which veterinary professionals can join the Register, what they need to do to stay on the Registers, how they may leave or be removed and registration appeals.
As Director of Legal Services, she'll provide leadership and guidance on legal matters within the organisation, including guiding RCVS Council through the development of oral and written legal advice, as well as sitting on committees and working groups in order to ensure the College’s activity is within its legal remit and represents best practice.
RCVS Chief Executive Officer Lizzie Lockett said: “I am sure the RCVS, the professions and the public will benefit from her very relevant experience from senior roles within the General Dental Council, Nursing and Midwifery Council, and Financial Conduct Authority, as well as her private sector legal experience.
“She joins the College at a time of change, with our continued push for new veterinary legislation, the ongoing Competition and Markets Authority investigation of the sector, and a new strategic plan for the College due to be approved this spring.
“The Registrar is the senior legal figure within the organisation, and I am looking forward to Clare contributing her legal expertise on these significant areas of work.
"She joins our very capable legal team, who I am sure will benefit from her leadership, as she will benefit from their sector expertise.”
Clare said: “I am delighted to join the Royal College of Veterinary Surgeons to contribute to the valuable work of safeguarding the interests of the public and animals by supporting veterinary professionals to provide the highest standards of care.”
VetSurgeon.org extends a warm welcome to Clare and wishes her all the very best in her new position.
One small but nevertheless important point is that perhaps a better aim would be to support veterinary professionals in providing just a 'high' standard of care, rather than the 'highest' standards.
It's this constant striving for the 'highest' standards from both a regulatory and clinical perspective that is driving up the cost of veterinary care and making it unaffordable.
The National Office of Animal Health has completed its annual review of its Code of Practice for the Promotion of Animal Medicines, and a number of changes will come into effect on 1st July 2011.
One change spells out the way antimicrobial medicines are promoted to farmers, with a firm emphasis on correct use and education.
Advertisers will be required to describe the condition the product is aiming to treat, and to promote an understanding of the treatment of the disease.
The phrase "use medicines responsibly" will always be included in text, making the voluntary strapline introduced in 2009 a formal part of the NOAH Code. As with all promotions to people other than prescribers, farmers will always be reminded to consult their veterinary surgeon.
Advertising text will always state clearly the name of the company and the brand being promoted, and promotion must not be designed to disguise its real nature.
Withdrawal periods for products will be stated, but these must not be unduly prominent and not in a font size greater than the body copy containing recommended dosage and species description.
The changes were proposed by NOAH within its formal response to the Veterinary Medicines Directorate's consultation on the Veterinary Medicines Regulation 2010. The Minister decided in December 2010 to continue to allow the advertising of antimicrobial veterinary products to farmers.
Phil Sketchley, NOAH Chief Executive, said: "Whilst welcoming the Government's decision in December not to further restrict the advertising of animal medicines, we feel that the industry should take a proactive role to ensure the system works properly. We believe it is important for farmers, who are legally responsible for the health and welfare of their animals and the food produced from them, to be aware of the medicines that are available to protect the health of their animals, and at the same time we want them to know that these medicines must be prescribed and used responsibly.
"The issue of antimicrobial resistance is one that affects us all. The way to promote best practice is through education by maintaining all lines of communication between farmers, vets, scientists and animal medicine producers.
"Antibiotics are essential for maintaining the health and welfare of all animals, but like any medicine they need to be used responsibly in order to maintain their effectiveness, and their availability for future generations."
The company says ligation clips, used to clamp vessels, have been used in complex surgeries on humans (including heart surgeries) since the 1980’s, but have only been introduced in veterinary practice in recent years.
Vet Direct has been showcasing the clips at the recent BSAVA and AVA shows, and says it has been surprised at the level of interest in the product.
Leon Wright, managing director at Vet Direct, said: "The ligation clips caused a big noise at our recent events, which is probably down to the benefits they offer. Not only are they quicker and easier, you get immediate vessel closure which reduces the amount of time a patient has to endure under general anesthetic. I’m confident that they’ll be a great help to all veterinary surgeons."
The company says it has already seen several clients make use of the clips, most frequently in common surgeries such as splenectomies and cholecystectomies.
For more information, visit www.vet-direct.com or call 0800 068 3300.
Sheila Wills BSc BVetMed CertSAM DipECVIM-CA MRCVS, specialist in internal medicine, has joined Wey Referrals, the Surrey-based multi-disciplinary veterinary referral practice.
Professor John Innes, Referral Director at CVS (of which Wey Referrals is a part) said: "We are delighted to welcome Sheila to our specialist team at Wey Referrals. Her experience and knowledge will further strengthen the service we offer and her appointment is another important step in the development of our referral team in the South East. Attracting the highest calibre talent is important to CVS because we want to build a referral team, whose members are not only clinically excellent but who also possess first rate communication and inter-personal skills."
Sheila said: "I am excited to be joining the CVS specialist team and look forward to working with like-minded colleagues who are passionate and dedicated to providing the highest level of patient care and client communication. I am delighted to be able to offer a specialist internal medicine service in both feline and canine medicine and look forward to offering a comprehensive service to CVS clients and expanding the internal medicine service further in the future."
Sheila graduated from the Royal Veterinary College in 1998 and spent five years in small animal practice before undertaking an FAB Residency in Feline Medicine at the University of Bristol.
Shortly after her residency, she was appointed Head of Small Animal Medicine and the Feline Centre at the Animal Health Trust where she was based for two years before moving to a major veterinary laboratory in December 2009. She recently returned to the University of Bristol as a teaching fellow in feline medicine.
Sheila acquired her ECVIM Diploma in Internal Medicine in September 2010 and is a Recognised European Veterinary Specialist in Internal Medicine. She became an RCVS Recognised Specialist in Feline Medicine in March 2012 and enjoys all aspects of feline medicine with a specialist interest in feline renal and ureteric disease. She is a member of the ICC Feline Expert Panel and an editorial board member for the Journal of Feline Medicine and Surgery.
Alstoe Animal Health is launching Nelio, a four-way breakable flavoured tablet version of the ACE inhibitor benazepril hydrochloride at BSAVA Congress.
The Nelio range for the treatment of congestive heart failure in dogs and chronic renal insufficiency in cats is presented as a flavoured clover-shaped scored tablet, which is easily divisible into halves or quarters. Nelio is presented in 5mg and 20mg tablets for dogs and 5mg for cats. The company says the new product will allow for more accurate dosing by bodyweight.
In addition, Alstoe is introducing a 120mg sized Dolagis chewable flavoured tablet, which contains the largest amount of carprofen in a single tablet on the veterinary market. As with the 50mg version, the 120mg tablet can be broken into half and quarter portion doses. Alstoe says the combination of these two sizes now affords even greater versatility for veterinary surgeons who need to prescribe for different weights of patient.
The Council of the Royal College of Veterinary Surgeons has approved a new Health Protocol, which formalises a more compassionate approach to veterinary surgeons with health problems.
The Protocol will allow - in appropriate circumstances - veterinary surgeons (and, from next year, registered veterinary nurses) who suffer from health concerns affecting their ability to practise safely, to have the matter dealt with confidentially, without going to a full public Disciplinary Committee hearing.
It will allow individuals to access appropriate support and help away from the public spotlight, while ensuring that they do not put animals or the public at risk.
According to independent legal advice sought by the College, such an approach is appropriate and necessary in order for the College to fulfil its regulatory responsibilities - similar systems exist within other regulators.
The draft Protocol was the subject of consultation amongst the profession and the public over summer. Proposed amendments to the RCVS Guide to Professional Conduct, to support the introduction of the Health Protocol, were also approved in the November meeting.
RCVS Head of Professional Conduct, Gordon Hockey said: "The Protocol encourages anyone coming into contact with veterinary surgeons - including other veterinary surgeons, veterinary nurses, members of practice staff, clients and healthcare professionals - who have concerns about a veterinary surgeon's health to report those concerns to the RCVS as soon as is reasonably practicable.
"Veterinary surgeons and veterinary nurses who are concerned about the health of a veterinary surgeon must also take steps to ensure that animals are not put at risk and that the interests of the public, including those of their colleagues, are protected."
Zoetis, formerly Pfizer Animal Health, has launched Flexi4, a nutritional supplement for horses containing a patented combination of natural plant extracts designed to help maintain joint flexibility and the management of joint pain.
Flexi4 contains a blend of four plant extracts, Curcumin, Yucca schidigera, Salix alba and Boswellia serrata, which the company says have been shown to have anti-inflammatory, anti-pyretic and analgesic properties as follows:
Mary King, Olympic three day eventing team silver medallist, said: "When performing at the highest level it's important that my horses' joints remain flexible and free of pain. Using Flexi4 has made them more resilient to aches and pains during intense training and I am confident when competing that my horses are feeling the benefit of this natural product, helping them to perform at their very best."
Flexi4 is an apple-flavoured gel that is fed as a once daily supplement. It doesn't contain any substances listed as prohibited by the FEI.* For more information, contact your Zoetis Account Manager, call 0845 300 8034 or email customersupportuk@zoetis.com.
References
*FEI prohibited substance list, 2013
The existing MSD Animal Health Connect Bursary and Ruminant Research Bursary have been combined into the new MSD Animal Health Research Bursary which is designed to support the future of the veterinary profession through research.
The student arm of the new Research Bursary will award £1,000 to the five best research project applications received from veterinary students across all UK veterinary schools, with an opportunity for an additional £1,000 top prize and £500 runner-up prize.
The veterinary surgeon arm of the Research Bursary will offer three awards, consisting of two ruminant awards and one companion animal award, of up to £4,000 each. The veterinary practitioner proposals will be judged by University academics to ensure independent assessment.
Michelle Townley, Veterinary Advisor at MSD Animal Health said: "Our existing Research Bursaries are well known amongst students and practitioners, having run for over 25 years for the student bursary and 6 years for the ruminant bursary. To increase our support for the veterinary profession through research we have decided to combine our Research Bursaries and add some new categories to help appeal to as wide an audience as possible. This way we can offer a broader level of support for both existing companion animal and ruminant practitioners and our veterinary surgeons of the future. We aim to engage as many people as possible so the MSD Animal Health Research Bursary will be supported by a new website page and social media package to encourage as much interest from students and practitioners as possible."
Student bursary applications are now invited, with a deadline for entries of Friday 26th May 2017. Veterinary practitioners will be invited to apply in September 2017.
For further details go to the MSD Animal Health Research Bursary website at www.msd-animal-health.co.uk/researchbursary.aspx.
250 mainly menopausal-aged veterinary surgeons and nurses took part in the survey.
Over 80% said the menopause had affected their health. Nearly half said the impact on their mental health had been moderate to severe. Overall, 76% said they were concerned about the impact of the menopause on their health, life and work.
You can read the full survey report here.
The most commonly reported physical symptoms, affecting over three quarters of respondents, were fatigue, irritability and difficultly sleeping. Hot flushes, night sweats and joint pain were also very common. Anxiety was the most common mental health impact, with some individuals experiencing clinical depression and, rarely, suicidal ideation.
Workplace measures said to be helpful included flexible working, help with heavy lifting and provision of fans or air conditioning. Diary management to allow breaks, and openness and understanding amongst colleagues were also valued.
Liz Barton, editor of Veterinary Woman said: “As a predominantly female workforce, we cannot ignore the profound impact the menopause can have both on individuals and veterinary teams. The effects last for an average of seven years and impact a majority of women mid-career. As a profession we have an opportunity to lead this conversation as it’s beginning to open up across the wider media."
Awareness of the impact of menopause was wide-ranging across age categories, but averaged 4.3 out of 10 for those 40 years old and under, and increased to 7.4 out of 10 for those aged 41 and over. Even with relatively high levels of awareness among respondents, 90% said they would like to know more about the impacts from either personal and/or business and human resource perspectives.
SPVS President, Anna Judson (pictured right), said: “Having experienced the effects of the menopause working as a practice owner, I wish I had known more about the impact and that I was not alone in how I was feeling. It’s time to break these taboos, open up the conversation and put in place measures to mitigate the impacts. In so doing, we will not only help individuals to continue to thrive in their careers, but also help practices to retain experienced staff at this challenging time of life."
A free access webinar discussing menopause impacts and how to mitigate is available free at: https://www.veterinarywoman.co.uk/2020/11/menopause-and-the-effect-on-veterinary-professionals-and-teams/
For the research, Which? conducted an online poll of 1,009 pet owners who had had an issue with their vet in the past two years.
It also conducted qualitative interviews with 14 owners who had complained.
The most common reasons for complaint were:
Of the 1009 pet owners who had experienced some kind of problem with their vet, 57% did NOT make a complaint, 33% because they did not want to fall out with their vet.
Pet owners who wish to complain about veterinary services have three options: to complain directly to their practice, to use the voluntary Vet Client Mediation Service (VCMS), or to raise a 'concern' with the RCVS.
The Which? report found that of those who did complain to their practice, 35% were not happy with the outcome and 31% with the way it was handled.
Which? found that although the VCMS reported a high resolution rate of 84% in 2022-23, its interviewees had found it a bit hit or miss.
Finally, Which? found the process of complaining to the regulator flawed by the fact that the threshold for the College to progress a 'concern' is set so high, because College has no jurisdiction at a practice level, and because it has no sanctions to use in enforcing consumer law.
The report recommends that:
Full report: https://www.which.co.uk/policy-and-insight/article/complaints-and-redress-in-veterinary-services-a5z611X9tZzf
CommentI loved the regal response from the RCVS to The Guardian about the case studies in the Which? report: “the facts presented in the case studies do not completely align with those reported to us”.
That aside, surely the big issue here is not so much that consumers have little way to complain effectively.
That is important, of course, but isn't it more important to consider what they are complaining about, which in the main is MONEY.
Driven by the advances in veterinary medicine, the innate desire of vets to provide the best possible care, anthropomorphising pet owners saying they want 'the best' for their fur baby (without necessarily having the wherewithal), corporatisation and society's changing expectations about working conditions, prices have been going up at a rate far outstripping inflation.
Increasing prices have of course been accompanied by an increase the standards of care and the range of clinical equipment.
But the question everyone must ask is at what point the cost of veterinary care for a dog outstrips the benefits of owning one?
These complaints are the canary in the coalmine.
Two recently published studies have demonstrated that the canine anti-emetic Cerenia® (maropitant - Pfizer) which was launched last year also relieves car sickness in dogs.
In a pilot study, 17 dogs were given either Cerenia or placebo one hour before being taken on a car journey. After a washout period of 10-14 days, each dog was crossed over to the other treatment and once again taken on a journey to assess travel sickness. The results showed that likelihood of vomiting was reduced by 70% when the dogs were given Cerenia compared to placebo – but due to the small number of dogs enrolled the results did not reach statistical significance.
The same research group also carried out a large, multicentre, blinded and placebo controlled study of Cerenia in preventing vomiting in 213 dogs known to be prone to travel sickness. They were given a single oral dose of Cerenia or placebo one hour before a car journey. The results showed that Cerenia was associated with a reduction in vomiting of 79% compared to placebo (p<0.0001).
The dosage of Cerenia used in both studies was 8mg/kg dose for the prevention of motion sickness–higher than the 2mg/kg dose that is routinely used to treat general emesis, administered at least one hour before the journey. According to the researchers’ report in the Veterinary Record, the need for a higher dose is linked to the specific neural (central) pathway of emetic stimulation that is involved in motion sickness. Cerenia acts primarily at NK1 receptors in the emetic centre and thus has the ability to block vomiting due to vestibular stimuli.
According to Pfizer, a single oral dose lasts for at least 12 hours, so pets can be dosed the night before an early start. For motion sickness prevention, Cerenia is licensed for up to 2 days’ consecutive use, so owners can use it for a return journey the next day if need be.
Pfizer also says that market research suggests almost one in five dogs suffers from travel sickness, which is not only inconvenient but does also stop some owners from travelling with their pet. In the past, owners have had to rely on OTC (over the counter) remedies or medicines developed for use in humans to prevent travel sickness. Many of these are ineffective or have unwanted effects such as sedation or extrapyramidial effects in dogs. Cerenia is the first anti-emetic to be developed specifically for use in dogs and was launched in April 2007– higher dose tablets aimed specifically for the prevention of travel sickness are expected to be made available early this year.
The Royal College of Veterinary Surgeons has embarked upon the most extensive review of its veterinary nursing qualifications for many years, in order to meet the timetable for Ofqual's implementation of the Qualifications and Credit Framework (QCF) in summer 2010.
The new QCF aims to provide a more user-friendly and flexible system. Under the new arrangements, all qualifications will carry a 'value' in terms of their level and the volume of learning involved. It's a similar system to that used in higher education for a number of years.
The new national awards framework means that NVQs as such will disappear and the process of review opens up the whole qualification structure, allowing for the creation of a more flexible system to suit better the needs of the veterinary nursing profession and employers.
Head of Veterinary Nursing, Libby Earle said: "Future options include potentially placing more of the responsibility for education and basic skills on the colleges, leaving practices to concentrate on providing quality mentorship and work experience, with less emphasis on assessment.
"Consideration will also be given to providing part of VN training and education within full-time further education, which is possible now that the lower age limit for VN students has been dropped."
The College is keen to hear the views of those involved with the delivery of training and employers of qualified nurses. A consultation letter has been sent to those involved and topics on which views are sought include the range and level of knowledge and skills delivered by the current awards, the impact of training on employers of student VNs, meeting the increased demand for qualified VNs, and providing VNs for mixed or equine practices.
Over the summer, evidence-gathering meetings will be held at the RCVS to explore the issues in more depth. Anyone who has not been sent a formal consultation letter and who would like to contribute is very welcome to submit their views. Please visit www.rcvs.org.uk/vnawardsreview for the consultation papers. Comments should be submitted by 30 June 2009.
The review of the RCVS awards will take place alongside Lantra's review of the National Occupational Standards (NOS) for VNs: the NOS describe what a person needs to do, know and understand in their job to carry out their role in a consistent and competent way.
VetCell Bioscience has become the first UK-based stem cell centre to be authorised under the Veterinary Medicines Regulations.
Following a rigorous series of inspections and reports by Good Manufacturing Practice (GMP) Inspectors VetCell, in conjunction with their UK laboratory partner Biobest, were officially authorised as an equine stem cell centre on 1 October 2009.
David Mountford, Chief Operating Officer of VetCell Bioscience said: "To have received formal authorisation so swiftly reflects the high standard of our operation and our ability to lead the field in the increasingly competitive sector of stem cell technology."
Stem cell therapy involves implanting millions of the animal's own stem cells and autologous growth factors directly into the injured tendon or ligament. The service VetCell Bioscience offers is the collection, storage, processing and supply of stem cells suitable for administration back into the donor animal.
According to the company, there is considerable interest from the human sector and studies in human medicine, for the treatment of Achilles tendinopathies, could begin as early as next year.
Thought to be the first agreement of its kind between a buying group and a veterinary practice, Norfolk Farm Vets and agricultural purchasing group Anglia Farmers Limited have come together to offer mutual members and clients a beneficial discount on their monthly vet account when invoiced through Anglia Farmers. Anglia Farmers livestock manager Simon Leach said: "With more than 650 livestock members, Anglia Farmers is keen to give a financial edge wherever possible. Veterinary costs are as much a part of the overall costs we already help with such as feed, equipment and fencing. In terms of dairy, they account for around 0.8p a litre of milk, accumulating to an average of around £1,200 a month for a typical East Anglian dairy of 150 head. Our discount agreement with Norfolk Farm Vets is a very positive step in aiding our members to save even more money through Anglia Farmers."Both parties agree that the time and administration cost saving benefit is equally important.Molly McKay of Norfolk Farm Vets, which has clients throughout the Eastern Counties as well as Lincolnshire, said: "Anyone involved with livestock knows how time-consuming all the paperwork can be. Each month Anglia Farmers collates all the supplier invoices, sends them on to members as part of their monthly statement with a single covering invoice which is so much easier than receiving them piecemeal. And it streamlines administration and cashflow for us as well."
Genitrix has announced the reformulation of Cerusolve, which cleans and deodorises the external ear canal of cats and dogs.
According to the company, the reformulation has enhanced Cerusolve's exfoliant and keratolyic properties and has given it a new fresh fragrance. Cerusolve ingredients now include:
Cerusolve is presented in a 100 ml bottle with a soft canula for application. It is priced at £5.65.
Genitrix Marketing Director Rob Watkins said: "Cerusolve has proved itself in practice as a gentle but effective ear cleaner in dogs and cats. The reformulation has given us the opportunity to increase the acidity of the product following a recent study which suggested that topical acidifying products could be therapeutically beneficial for cutaneous yeast infections.
"We believe the new ingredients will enhance the product and, to celebrate its arrival, we're offering practices the opportunity to buy five bottles of Cerusolve and get one free."
Further details are available from Genitrix on 01403 786345.
The webinars each last between three and five minutes and are part of the 2016 ‘Talk About Laminitis’ disease awareness initiative to help detect, manage and monitor PPID.
The webinars can be viewed on the Boehringer Academy website – www.boehringer-academy.co.uk - and podcast versions are also available enabling veterinary professionals to listen to them ‘on the go’.
The first series includes:
The second webinar series covers:
For further information on the webinars or podcasts visit www.boehringer-academy.co.uk or contact your local Boehringer Ingelheim territory manager.
The procedure involves introducing a catheter through the jugular, then using fluoroscopy and transoesophageal echocardiography to guide it from the right atrium through to the left side of the heart to relieve abnormal high pressures in the left atrium.
Willows says it is one of only a few centres across Europe equipped to carry out the procedure and that typically, patients who undergo TSP can be discharged from hospital the day after surgery.
Fabio Sarcinella (pictured right), an RCVS and European specialist in small animal cardiology at Willows, said: “Early clinical evaluation of the TSP procedure in humans over the last few years has shown improved quality of life and reduced clinical signs in patients with heart failure.
“The procedure has also been associated with low-risk and a meaningful drop in left atrial pressure of the affected patients.”
Fabio added: “As well as being minimally invasive, the improvement in heart chamber pressures via TSP often allows for a reduction in the dose of water tablets which are used to control the heart failure signs in the lungs.
"Lowering the dose reduces the risk of side effects related to these drugs such as kidney failure.”
Willows says TSP is most commonly used for left atrial decompression in dogs with heart failure and concurrent renal disease or that have advanced heart failure but continue to have symptoms despite optimal medical treatment.
www.willows.uk.net